The burden and outcome of nasopharyngeal carcinoma in Sweden
DOI:
https://doi.org/10.2340/1651-226X.2025.43700Keywords:
Nasopharyngeal carcinoma, Epstein-Barr Virus, Swedish Head and Neck Cancer RegisterAbstract
Introduction: The purpose of this study is to present the nationwide disease burden and survival of nasopharyngeal carcinoma (NPC) in Sweden. The subcohort from the Stockholm-Gotland region was included to investigate the prevalence of Epstein-Barr virus (EBV) in NPC and to describe pattern of relapse.
Methods: This population-based nationwide study included patients diagnosed with NPC in Sweden during 2008–2021. The series was retrieved from the Swedish Head and Neck Cancer Register. Age at diagnosis, sex, tumor histopathology, stage, treatment intent, treatment, radiation dose, follow-up time, time to relapse, and site of relapse were recorded. The Stockholm-Gotland region series was used to obtain an updated histopathological analysis including EBV status and to analyze site of relapse.
Results: The nationwide study cohort comprised 399 patients, 33% were female. Mean age at diagnosis did not differ between the sexes: 56.3 years for females, 57.5 years for males. Seventy-one percent presented with Stage III or IV. The 5-year overall survival (OS) was 73.2%. In the regional cohort, 73.9% were EBV positive. In the competing risk analysis, the cumulative incidence of distant metastatic relapse was higher than that of local and/or regional relapse at 5 years (18.7% vs. 12.4%). However, the confidence intervals were wide, and the difference should be interpreted with caution.
Interpretation: The survival outcome in our study seems comparable to previous studies in nonendemic countries. There was a high percentage of EBV-positive tumors compared with the previous studies in nonendemic countries.
Downloads
References
Guo LF, Hong JG, Wang RJ, Chen GP, Wu SG. Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas. Ann Med. 2024;56(1):2425066.
https://doi.org/10.1080/07853890.2024.2425066 DOI: https://doi.org/10.1080/07853890.2024.2425066
Ferlay JEM, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, et al. https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf [Internet]. Lyon: International Agency for Research on Cancer; 2024 [cited 2024 Oct 10]. Available from: https://gco.iarc.who.int/today
WHO Classification of Tumours Editorial Board. Head and neck tumours [Internet]. Lyon, France: Agency for Research on Cancer; 2023 [cited 2025 Mar 21]. Available from: https://tumourclassification.iarc.who.int/chapters/52
Wu SG, Lian CL, Wang J, Zhang WW, Sun JY, Lin Q, et al. The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up. Ann Transl Med. 2019;7(23):768.
https://doi.org/10.21037/atm.2019.11.75 DOI: https://doi.org/10.21037/atm.2019.11.75
Lee AW, Ng WT, Chan LL, Hung WM, Chan CC, Sze HC, et al. Evolution of treatment for nasopharyngeal cancer – success and setback in the intensity-modulated radiotherapy era. Radiother Oncol. 2014;110(3):377–84.
https://doi.org/10.1016/j.radonc.2014.02.003 DOI: https://doi.org/10.1016/j.radonc.2014.02.003
Limkin EJ, Blanchard P. Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma. Br J Radiol. 2019;92(1102):20190068.
https://doi.org/10.1259/bjr.20190068 DOI: https://doi.org/10.1259/bjr.20190068
Xue WQ, Qin HD, Ruan HL, Shugart YY, Jia WH. Quantitative association of tobacco smoking with the risk of nasopharyngeal carcinoma: a comprehensive meta-analysis of studies conducted between 1979 and 2011. Am J Epidemiol. 2013;178(3):325–38.
https://doi.org/10.1093/aje/kws479 DOI: https://doi.org/10.1093/aje/kws479
Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015;33(29):3356–64.
https://doi.org/10.1200/JCO.2015.60.9347 DOI: https://doi.org/10.1200/JCO.2015.60.9347
Jia WH, Huang QH, Liao J, Ye W, Shugart YY, Liu Q, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178.
https://doi.org/10.1186/1471-2407-6-178 DOI: https://doi.org/10.1186/1471-2407-6-178
Wei X, Chen B, Wang Z, Zhao P, Duan X. Nasopharyngeal cancer risk assessment by country or region worldwide from 1990 to 2019. BMC Public Health. 2024;24(1):1931.
https://doi.org/10.1186/s12889-024-19228-9 DOI: https://doi.org/10.1186/s12889-024-19228-9
Register TSHaNC. The Swedish Head and Neck Cancer Register, SweHNCR Presentation in English 2020 Regionalt cancercentrum väst, Västra sjukvårdsregionen 2020 [Internet]. [cited 2025]. Available from: https://cancercentrum.se/download/18.3de350c219545ea25bd220e1/1741017690273/presentation-in-english-swehncr.pdf [Cited 2025-05-28]
Jakobsen KK, Hjuler T, Laier GH, Von Buchwald C, Grønhøj C. Incidence of head and neck cancer in adolescents and young adults: a Danish nationwide study from 1978–2014. Acta Oncol. 2021;60(3):343–6.
https://doi.org/10.1080/0284186X.2020.1828618 DOI: https://doi.org/10.1080/0284186X.2020.1828618
Bressler SE, Evans AK. Pediatric non-nasopharyngeal head and neck squamous cell carcinoma: analysis of the Surveillance, Epidemiology, and End Results (SEER) program with review of the literature. Int J Pediatr Otorhinolaryngol. 2024;186:112135.
https://doi.org/10.1016/j.ijporl.2024.112135 DOI: https://doi.org/10.1016/j.ijporl.2024.112135
Schiess E, Jensen KH, Kristensen MH, Johansen J, Eriksen JG, Maare C, et al. Epidemiology and treatment outcome of nasopharyngeal carcinoma in a low-incidence population – a DAHANCA analysis in Denmark 2000–2018. Acta Oncol. 2024;63:850–7.
https://doi.org/10.2340/1651-226X.2024.40499 DOI: https://doi.org/10.2340/1651-226X.2024.40499
Ruuskanen M, Grenman R, Leivo I, Vahlberg T, Makitie A, Saarilahti K, et al. Outcome of nasopharyngeal carcinoma in Finland: a nationwide study. Acta Oncol. 2018;57(2):251–6.
https://doi.org/10.1080/0284186X.2017.1346378 DOI: https://doi.org/10.1080/0284186X.2017.1346378
Nilsson JS, Forslund O, Andersson FC, Lindstedt M, Greiff L. Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer. Sci Rep. 2019;9(1):15432.
https://doi.org/10.1038/s41598-019-51767-9 DOI: https://doi.org/10.1038/s41598-019-51767-9
Svajdler M, Jr., Kaspirkova J, Mezencev R, Laco J, Torday T, Dubinsky P, et al. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population. Neoplasma. 2016;63(1):107–14.
https://doi.org/10.4149/neo_2016_013 DOI: https://doi.org/10.4149/neo_2016_013
Tatlı Doğan H, Kılıçarslan A, Doğan M, Süngü N, Güler Tezel G, et al. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients. Pathol Res Pract. 2016;212(11):1021–6.
https://doi.org/10.1016/j.prp.2016.08.013 DOI: https://doi.org/10.1016/j.prp.2016.08.013
Simon J, Schroeder L, Ingarfield K, Diehl S, Werner J, Brenner N, et al. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country. Int J Cancer. 2020;147(2):461–71.
https://doi.org/10.1002/ijc.33006 DOI: https://doi.org/10.1002/ijc.33006
The Swedish Head and Neck Cancer Register, SweHNCR Presentation in English https://cancercentrum.se/download/18.3de350c219545ea25bd220e1/1741017690273/presentation-in-english-swehncr.pdf: © 2020 Regionalt cancercentrum väst, Västra sjukvårdsregionen [Internet]. 2020 [cited 2025 May 29]. Available from: https://cancercentrum.se/download/18.3de350c219545ea25bd220e1/1741017690273/presentation-in-english-swehncr.pdf
Perme MP, Stare J, Estève J. On estimation in relative survival. Biometrics. 2012;68(1):113–20.
https://doi.org/10.1111/j.1541-0420.2011.01640.x DOI: https://doi.org/10.1111/j.1541-0420.2011.01640.x
Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007;40(4):381–7.
https://doi.org/10.1038/sj.bmt.1705727 DOI: https://doi.org/10.1038/sj.bmt.1705727
Ruuskanen M, Irjala H, Minn H, Vahlberg T, Randen-Brady R, Hagstrom J, et al. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: a nationwide study in Finland. Head Neck. 2019;41(2):349–57.
https://doi.org/10.1002/hed.25450 DOI: https://doi.org/10.1002/hed.25450
Au KH, Ngan RKC, Ng AWY, Poon DMC, Ng WT, Yuen KT, et al. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study). Oral Oncol. 2018;77:16–21.
https://doi.org/10.1016/j.oraloncology.2017.12.004 DOI: https://doi.org/10.1016/j.oraloncology.2017.12.004
Tian Y, Huang WZ, Zeng L, Bai L, Han F, Lan Y. The failure patterns of nasopharygeal carcinoma after intensity-modulated radiotherapy and implications for surveillance. Cancer Manag Res. 2022;14:2813–23.
https://doi.org/10.2147/CMAR.S347864 DOI: https://doi.org/10.2147/CMAR.S347864
Tian YM, Liu MZ, Zeng L, Bai L, Lin CG, Huang SM, et al. Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Head Neck. 2019;41(5):1246–52.
https://doi.org/10.1002/hed.25545 DOI: https://doi.org/10.1002/hed.25545
Aldhahri SF, Barakeh MM, Almetary RJ, Alfirm RB, Almousa HM, Alsubaie HM. Patterns of treatment failure in patients with nasopharyngeal carcinoma and salvage treatment outcome: a retrospective analysis study. Am J Otolaryngol. 2023;44(5):103941.
https://doi.org/10.1016/j.amjoto.2023.103941 DOI: https://doi.org/10.1016/j.amjoto.2023.103941
Liu JC, Bhayani M, Kuchta K, Galloway T, Fundakowski C. Patterns of distant metastasis in head and neck cancer at presentation: implications for initial evaluation. Oral Oncol. 2019;88:131–6.
https://doi.org/10.1016/j.oraloncology.2018.11.023 DOI: https://doi.org/10.1016/j.oraloncology.2018.11.023
Colaco RJ, Betts G, Donne A, Swindell R, Yap BK, Sykes AJ, et al. Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol (R Coll Radiol). 2013;25(3):171–7.
https://doi.org/10.1016/j.clon.2012.10.006 DOI: https://doi.org/10.1016/j.clon.2012.10.006
Bossi P, Trama A, Bernasconi A, Grisanti S, Mohamad I, Galiana IL, et al. Nasopharyngeal cancer in non-endemic areas: impact of treatment intensity within a large retrospective multicentre cohort. Eur J Cancer. 2021;159:194–204. DOI: https://doi.org/10.2139/ssrn.3812378
https://doi.org/10.1016/j.ejca.2021.09.005 DOI: https://doi.org/10.1016/j.ejca.2021.09.005
Arnold M, Wildeman MA, Visser O, Karim-Kos HE, Middeldorp JM, Fles R, et al. Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology. Oral Oncol. 2013;49(3):237–43.
https://doi.org/10.1016/j.oraloncology.2012.09.016 DOI: https://doi.org/10.1016/j.oraloncology.2012.09.016
Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS, Zeng YX, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016;374(1):22–30.
https://doi.org/10.1016/j.canlet.2016.01.040 DOI: https://doi.org/10.1016/j.canlet.2016.01.040
Zhao BY, Hirayama S, Goss D, Zhao Y, Faden DL. Human papillomavirus-associated nasopharyngeal carcinoma: a systematic review and meta-analysis. Oral Oncol. 2024;159:107057.
https://doi.org/10.1016/j.oraloncology.2024.107057 DOI: https://doi.org/10.1016/j.oraloncology.2024.107057
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours. International Agency for Research on Cancer; 2017. 69366 LYON CEDEX 07, France.
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Evelina Gille, Anders Näsman, Madeleine Helmersson, Elin Marsk, Antti Mäkitie, Lalle Hammarstedt-Nordenvall
This work is licensed under a Creative Commons Attribution 4.0 International License.
